CNMD CONMED Corp
- Stocks
- Healthcare
- NASDAQ: CNMD
Price (delayed)
$54.67
Market cap
$1.69B
P/E Ratio
15.36
Dividend/share
$0.8
EPS
$3.56
Enterprise value
$2.54B
CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties,
Highlights
The stock's price to earnings (P/E) is 95% less than its 5-year quarterly average of 317.9 and 2.8% less than its last 4 quarters average of 15.8
CNMD's equity is up by 14% YoY and by 2.6% from the previous quarter
The net income is up by 12% year-on-year but it has declined by 7% since the previous quarter
CNMD's EPS is up by 11% YoY but it is down by 7% QoQ
CNMD's quick ratio is down by 10% YoY
Key stats
What are the main financial stats of CNMD
Market
Valuations
Earnings
Shares outstanding
30.95M
Market cap
$1.69B
Enterprise value
$2.54B
Price to earnings (P/E)
15.36
Price to book (P/B)
1.69
Price to sales (P/S)
1.28
EV/EBIT
14.78
EV/EBITDA
13.44
EV/Sales
1.92
Revenue
$1.33B
Gross profit
$743.41M
Operating income
$171.91M
Net income
$110.2M
EBIT
$171.91M
EBITDA
$189M
Free cash flow
$148.24M
Per share
Balance sheet
Liquidity
EPS
$3.56
EPS diluted
$3.53
Free cash flow per share
$4.79
Book value per share
$32.41
Revenue per share
$42.85
TBVPS
$29.72
Total assets
$2.33B
Total liabilities
$1.33B
Debt
$881.83M
Equity
$1B
Working capital
$362.94M
Debt to equity
0.88
Current ratio
2.23
Quick ratio
0.91
Net debt/EBITDA
4.49
Margins
Efficiency
Dividend
EBITDA margin
14.3%
Gross margin
56.1%
Net margin
8.3%
Operating margin
13%
Return on assets
4.8%
Return on equity
11.4%
Return on invested capital
11.6%
Return on capital employed
8.5%
Return on sales
13%
Dividend yield
1.46%
DPS
$0.8
Payout ratio
22.5%
CNMD stock price
How has the CONMED stock price performed over time
Intraday
2.42%
1 week
4.55%
1 month
4.23%
1 year
-19.39%
YTD
-20.12%
QTD
4.97%
Financial performance
How have CONMED's revenue and profit performed over time
Revenue
$1.33B
Gross profit
$743.41M
Operating income
$171.91M
Net income
$110.2M
Gross margin
56.1%
Net margin
8.3%
The net income is up by 12% year-on-year but it has declined by 7% since the previous quarter
The company's net margin rose by 8% YoY but it fell by 8% QoQ
The operating income has increased by 6% year-on-year but it has declined by 5% since the previous quarter
The operating margin has declined by 6% since the previous quarter but it has grown by 2.4% year-on-year
Price vs fundamentals
How does CNMD's price correlate with its fundamentals
Growth
What is CONMED's growth rate over time
Valuation
What is CONMED stock price valuation
P/E
15.36
P/B
1.69
P/S
1.28
EV/EBIT
14.78
EV/EBITDA
13.44
EV/Sales
1.92
The stock's price to earnings (P/E) is 95% less than its 5-year quarterly average of 317.9 and 2.8% less than its last 4 quarters average of 15.8
CNMD's EPS is up by 11% YoY but it is down by 7% QoQ
The stock's price to book (P/B) is 56% less than its 5-year quarterly average of 3.8 and 16% less than its last 4 quarters average of 2.0
CNMD's equity is up by 14% YoY and by 2.6% from the previous quarter
CNMD's P/S is 54% less than its 5-year quarterly average of 2.8 and 15% less than its last 4 quarters average of 1.5
CNMD's revenue is up by 3.9% year-on-year
Efficiency
How efficient is CONMED business performance
CNMD's return on assets is up by 12% year-on-year but it is down by 8% since the previous quarter
The ROE has contracted by 10% from the previous quarter and by 2.6% YoY
CNMD's ROS is down by 6% QoQ but it is up by 2.4% YoY
CNMD's return on invested capital is up by 6% year-on-year but it is down by 4.9% since the previous quarter
Dividends
What is CNMD's dividend history
DPS
$0.8
Dividend yield
1.46%
Payout ratio
22.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did CONMED financials performed over time
CNMD's total assets is 76% greater than its total liabilities
CNMD's quick ratio is down by 10% YoY
The total liabilities has declined by 6% year-on-year
The company's debt is 12% lower than its equity
The company's debt to equity fell by 20% YoY and by 3.3% QoQ
CNMD's equity is up by 14% YoY and by 2.6% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.